These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7824183)

  • 1. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10.
    Brouillet E; Henshaw DR; Schulz JB; Beal MF
    Neurosci Lett; 1994 Aug; 177(1-2):58-62. PubMed ID: 7824183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.
    Beal MF; Henshaw DR; Jenkins BG; Rosen BR; Schulz JB
    Ann Neurol; 1994 Dec; 36(6):882-8. PubMed ID: 7998775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism.
    Beal MF; Swartz KJ; Hyman BT; Storey E; Finn SF; Koroshetz W
    J Neurochem; 1991 Sep; 57(3):1068-73. PubMed ID: 1830613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
    Schulz JB; Matthews RT; Henshaw DR; Beal MF
    Neuroscience; 1996 Apr; 71(4):1043-8. PubMed ID: 8684608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminooxyacetic acid produces excitotoxic brain injury in neonatal rats.
    McDonald JW; Schoepp DD
    Brain Res; 1993 Oct; 624(1-2):239-44. PubMed ID: 8252396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
    Brouillet E; Hyman BT; Jenkins BG; Henshaw DR; Schulz JB; Sodhi P; Rosen BR; Beal MF
    Exp Neurol; 1994 Oct; 129(2):175-82. PubMed ID: 7525331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
    Beal MF; Brouillet E; Jenkins B; Henshaw R; Rosen B; Hyman BT
    J Neurochem; 1993 Sep; 61(3):1147-50. PubMed ID: 7689641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum.
    Urbańska E; Ikonomidou C; Sieklucka M; Turski WA
    Synapse; 1991 Oct; 9(2):129-35. PubMed ID: 1821484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism.
    Brouillet EP; Shinobu L; McGarvey U; Hochberg F; Beal MF
    Exp Neurol; 1993 Mar; 120(1):89-94. PubMed ID: 8477830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen.
    Midgley LP; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Oct; 593(1):89-96. PubMed ID: 1360868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malonate produces striatal lesions by indirect NMDA receptor activation.
    Henshaw R; Jenkins BG; Schulz JB; Ferrante RJ; Kowall NW; Rosen BR; Beal MF
    Brain Res; 1994 May; 647(1):161-6. PubMed ID: 8069700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent neurotoxicity of striatal lesions produced by aminooxyacetic acid: quantitative in vitro 1H NMR spectroscopic studies.
    Chang C; Jang T
    J Neurochem; 1995 Sep; 65(3):1192-8. PubMed ID: 7643097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.
    Matthews RT; Yang L; Browne S; Baik M; Beal MF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8892-7. PubMed ID: 9671775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
    Beal MF; Matthews RT
    Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity.
    Schulz JB; Henshaw DR; Matthews RT; Beal MF
    Exp Neurol; 1995 Apr; 132(2):279-83. PubMed ID: 7789466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative influence of kolaviron and coenzyme Q10 on complex I activity, glutamate clearance, 3,4-dihydroxyphenethylamine metabolism, and redox stress in rotenone-induced neurotoxicity.
    Akinmoladun AC; Saliu I; Abilogun O; Ajibola OH; Amoo ZA; Ojo OB; Farombi EO; Olaleye MT
    Niger J Physiol Sci; 2022 Dec; 37(2):165-173. PubMed ID: 38243568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and pharmacological effects of centrally administered aminooxyacetic acid in rats.
    Vécsei L; Beal MF
    Eur J Pharmacol; 1992 Sep; 220(2-3):259-62. PubMed ID: 1385183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.
    Ferrante RJ; Schulz JB; Kowall NW; Beal MF
    Brain Res; 1997 Apr; 753(1):157-62. PubMed ID: 9125443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.